Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AXA SA (AXAHF) reported an 8% growth in revenue across all lines of business and geographies, translating into an 8% growth in underlying earnings per share. The company's solvency ratio stands at a solid 216%, indicating a strong capital position. AXA SA (AXAHF) announced a 9% increase in dividend per share and a new share buyback program of 1.2 billion euros, reflecting confidence in the business. The company has shown consistent earnings growth, with a 40% increase in profit and underlying earnings since 2016. AXA SA (AXAHF) has a balanced and focused business model, with strong positions in insurance markets across Europe, Japan, and Hong Kong. Negative Points The company faces political uncertainty in the US and Europe, although it has not yet impacted the business. Inflation in Europe, while receding, remains a concern for the insurance industry. AXA SA (AXAHF) is cautious about the increasing severity and frequency of natural catastrophes, which could impact future results. The investment in technology and AI has been a drag on earnings in 2024, although it is expected to benefit future performance. The company has experienced challenges in the UK and German retail markets, although improvements have been made. Q & A Highlights Warning! GuruFocus has detected 6 Warning Sign with AXAHF. Q: Given the strong performance, is there a chance AXA might revise its earnings growth plan from 6-8% to a higher range like some peers? Also, with the cash inflow, is AXA considering acquisitions? A: (Thomas Buel, CEO) We are maintaining our 6-8% growth target for now, despite the strong first-year performance. We will reassess if high numbers persist into the third year. Regarding acquisitions, while we occasionally explore opportunities, our primary focus remains on executing our current strategy, prioritizing dividends and share buybacks. Q: Can you elaborate on the growth potential in mid-market P&C and employee benefits? Are these areas contributing positively to your margins? A: (Frederick de Courtois, Deputy CEO) Yes, mid-market P&C generally offers higher margins than large corporate accounts. We are expanding in the US, UK, and Southern Europe, and initial results are promising. In employee benefits, margins are similar to individual protection and health, despite tough negotiations with large clients. Q: What is the outlook for AXA's CSM growth, and how does the grandfathered debt impact solvency? A: (Abon de Meinel, CFO) We aim to improve CSM growth progressively through positive net flows. The current 2% growth is below expectations, but we anticipate improvement. Regarding grandfathered debt, we have 4.5 billion left, and we will manage it strategically, considering solvency II revisions. Story Continues Q: With the momentum in various segments, why shouldn't we expect more than 8% earnings growth in 2025? A: (Thomas Buel, CEO) While there is strong momentum, we still have work to do in expanding margins and enhancing our life business dynamics. We prefer to see more progress in these areas before considering revising our growth targets. Q: How are you managing the volatility in the P&C combined ratio, and what is the plan for the XIM-related buyback? A: (Abon de Meinel, CFO) We manage volatility by balancing NATCAT, discounting, and PYD. The 3.8 billion buyback for XIM will be executed post-closing, likely in summer, with half completed this year and the rest next year. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
AXA SA (AXAHF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...